Deals Shaping The Medical Industry (02/2010)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
You may also be interested in...
Medical device manufacturers are operating in what may be the industry’s most challenging business and regulatory environment in recent history, attorneys Bill McConagha and Pamela Amaechi argue in this guest article.
Biolife4D CEO dropped president title and Cryo-Cell International co-chief executive officer dropped director title to open spots for new executives; Essex Bio-Technology deputy managing director was promoted to executive director; and more.
Novavax aims to recruit 10,000 subjects in the UK, and will include a flu vaccination co-administration for some participants.